期刊文献+

肺表面活化蛋白A相似分子在炎症肠道疾病组织中的过量表达(英文) 被引量:10

Overexpression of pulmonary surfactant protein A like molecules in inflammatory bowel disease tissues
下载PDF
导出
摘要 目的:阐明炎症肠道疾病(inlammatory bowel disease,IBD)中肺表面活化蛋白A(pulmonary surfactant protein A,SP-A)相似分子的分布特征和CD68阳性巨噬细胞的免疫反应。方法:外科手术获得的结肠组织标本来自布朗大学医学院罗得岛医院病理科,应用免疫组织化学方法检测IBD患者肠道组织中SP-A相似分子的表达。结果:SP-A相似分子分布在肠道上皮、肠道绒毛表面,连接组织血管和某些炎症细胞。具有SP-A相似分子和CD68阳性表达的巨噬细胞数量炎症区域明显增加,高于正常组织。而免疫荧光双标记实验显示,一些CD68阳性巨噬细胞可以表达SP-A相似分子免疫反应。结论:SP-A是肺脏一种重要的宿主防御因子。 Objective To investigate the distribution of pulmonary surfactant protein A ( SPA ) like molecules and the bridge of frontier host defense and adaptive immune response cell of CD68 positive macrophages in inflammatory bowel disease (IBD). Methods Surgical specimens derived from involved areas and normal area of the colon with Crohn disease (CD) and ulcerative colitis (UC) were obtained from Department of Pathology, Rhode Island Hospital, Brown University Medical Center. The distribution of SP-A like molecule in intestine of IBD was detected by immunohistochemistry. Results SP-A like molecule located in epithelia of intestine, the surface of intestine viii, blood vessels of connective tissue, and some inflammatory cells. The number of macro-phages with both SP-A like molecule and CD68 positive was dramatically increased in the inflammatory area than the normal area. Some CD68 positive macrophages expressed SP-A like immunoreactivity by immunofluorescence double labeling. Conclusion SP-A is an important host defense molecule in lung, and SP-A expression in large intestine may reflect a close relation between 2 organs in immune response towards inflammation.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2008年第11期979-986,共8页 Journal of Central South University :Medical Science
关键词 炎症肠道疾病 肺表面活化蛋白A相似分子 CD68 免疫组织化学 inflammatory bowel disease pulmonary surfactant protein A like molecules CD68 immunohistochemistry
  • 相关文献

参考文献2

二级参考文献142

  • 1Riina Salupere Docent of Gastroenterology,Department of Internal Medicine University of Tartu,Estonia.Inflammatory bowel disease in Estonia:a prospective epidemiologic study 1993-1998a[J].World Journal of Gastroenterology,2001,7(3):387-388. 被引量:13
  • 2JA Tibble,IBjarnason.Non-invasive investigation of inflammatory bowel disease[J].World Journal of Gastroenterology,2001,7(4):460-465. 被引量:10
  • 3[1]Bernstein CN,Blanchard JF,Rawsthorne P,Yu N.The prevalence of extraintestinal diseases in inflammatory bowel disease:a population-based study.Am J Gastroenterol 2001; 96:1116-1122 被引量:1
  • 4[2]Ricart E,Panaccione R,Loftus EV Jr,Tremaine WJ,Harmsen WS,Zinsmeister AR,Sandborn WJ.Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease:a case-control study.Inflamm Bowel Dis 2004; 10:207-214 被引量:1
  • 5[3]Bernstein CN,Wajda A,Blanchard JF.The clustering of other chronic inflammatory diseases in inflammatory bowel disease:a population-based study.Gastroenterology 2005; 129:827-836 被引量:1
  • 6[4]Mendoza JL,Lana R,Taxonera C,Alba C,Izquierdo S,DiazRubio M.Extraintestinal manifestations in inflammatory bowel disease:differences between Crohn's disease and ulcerative colitis.Med Clin (Barc) 2005; 125:297-300 被引量:1
  • 7[5]Bhagat S,Das KM.A shared and unique peptide in the human colon,eye,and joint detected by a monoclonal antibody.Gastroenterology 1994; 107:103-108 被引量:1
  • 8[6]Oshitani N,Watanabe K,Nakamura S,Higuchi K,Arakawa T.Extraintestinal complications in patients with ulcerative colitis.Nippon Rinsho 2005; 63:874-878 被引量:1
  • 9[7]Satsangi J,Grootscholten C,Holt H,Jewell DP.Clinical patterns of familial inflammatory bowel disease.Gut 1996; 38:738-741 被引量:1
  • 10[8]Roussomoustakaki M,Satsangi J,Welsh K,Louis E,Fanning G,Targan S,Landers C,Jewell DP.Genetic markers may predict disease behavior in patients with ulcerative colitis.Gastroenterology 1997; 112:1845-1853 被引量:1

共引文献41

同被引文献152

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部